To assess feasibility of method to estimate the costs of care, quality of life and wider societal burden (mortality, morbidity and lost productivity with economic impact on family) due to COPD



The data collected in this study were related to cost of illness (direct and indirect) related to COPD disease.
Date made available15 Mar 2022
PublisherEdinburgh DataVault

Cite this